Microbio Co., Ltd.

Microbio Co., Ltd. is a biotechnology company specializing in the research, development, manufacturing, and distribution of pharmaceutical products and dietary supplements. Its core business includes developing solutions for medical needs such as MS-20, targeted at fatigue and appetite loss related to cancer treatment, and Herbiron, designed to address iron deficiency anemia. The company has diversified activities ranging from the trading of organic foods and beverage sales to providing technology consultation and publishing services. Microbio Co., Ltd. supplies a variety of health foods, herbal products, botanical drugs, and disease prevention supplements, often serving as a key supplier of raw materials to other pharmaceutical firms in Taiwan. Incorporated in 2000 and headquartered in Taipei, it operates within the consumer staples sector, primarily impacting healthcare and health technology markets. The company is recognized for its commitment to innovation and quality in biotech solutions, and has achieved notable recognition for corporate governance, ranking among the top 5% of TPEx-listed companies in 2022. Its activities contribute significantly to Taiwan’s health technology and packaged foods industries, reinforcing its role as an influential player in the regional pharmaceutical and functional foods sector.